GNRH1 and endometriosis: GnRH antagonists, selective estrogen receptor modulators (SERMs), and selective progesterone receptor modulators (SPRMs) have shown potential in alleviating endometriosis-related symptoms while minimizing the systemic side effects associated with hormonal therapies.